Exploiting a Noble Name: Dr. Adeeb Rizvi and the Prolan Controversy
In recent times, there has been a growing wave of advertisements circulating across social media and other online platforms promoting Prolan as a miraculous or “ultimate curative” prescription for urological disorders, particularly prostatitis. What makes this campaign especially alarming is the recurring attempt to associate Prolan with the name of Dr. Adeeb-ul-Hassan Rizvi, the world-renowned urologist, humanitarian, and founder of the Sindh Institute of Urology and Transplantation (SIUT).
Of late, I came across video clips featuring Shahzeb Khanzada and Hamid Mir—both acclaimed television anchors—appearing to eulogize Dr. Rizvi’s supposed breakthrough in inventing Prolan, portraying it as an elixir and a major medical milestone in curing prostate-related ailments. Such media portrayals, especially when disseminated through widely followed public figures, tend to lend substantial credibility to the claims being made, persuading viewers to believe that Prolan is indeed a scientifically proven, “super cure.”
However, upon closer examination, doubts arise regarding the authenticity of these claims. I personally viewed a video in which a person resembling Dr. Rizvi appears to speak about Prolan, yet the voice and manner of expression did not match his well-known articulate and distinctly Urdu-speaking style. The diction, accent, and tone were markedly inconsistent with the genuine persona of Dr. Rizvi, casting serious doubt on the video’s legitimacy.
Dr. Rizvi’s towering stature as a medical pioneer and his lifelong service to humanity are beyond question. His integrity and dedication have made him a symbol of hope for countless patients across Pakistan. Therefore, using his name to promote an unverified drug not only misleads the public but also undermines his noble legacy. Exploiting the trust the people place in his name for commercial purposes is ethically reprehensible and potentially dangerous to those who may abandon proper medical consultation in pursuit of an unproven remedy.
It is high time that the Ministry of National Health Services, together with relevant media and drug regulatory authorities, take immediate notice of these developments. They must verify whether any credible scientific data or authorized statement from Dr. Rizvi supports the claims made about Prolan. Furthermore, media outlets should exercise due diligence in ensuring that no misleading or unsubstantiated health information is allowed to circulate unchecked.
The government should promptly issue a clear public clarification regarding Prolan’s authenticity and efficacy, thereby protecting the common people—especially the elderly suffering from prostatitis and related conditions—from being misinformed or exploited.
In an age where misinformation can travel faster than truth, the moral obligation of our institutions is to uphold accuracy, transparency, and public trust—values that Dr. Adeeb Rizvi himself has embodied throughout his illustrious life.
Comments